Recalls: FDA Reports Salmonella Contamination In More Kratom Supplements
This article is powered by The Rose Sheet
Executive Summary
FDA's list of recalls of health, beauty and wellness products that have been categories from April 25 through June 20 include products from nine other kratom supplement marketers. Drug-spiked products marketed as supplements also are included in FDA's list for the period.
You may also be interested in...
Kratom Group Contests FDA's Opioid Finding, Requests Joint Meeting With NIDA
American Kratom Association accuses FDA of using “inaccurate, extrapolated and distorted” information on adverse events and deaths allegedly associated with the use of kratom to justify scheduling it as a controlled substance. After FDA Commissioner Gottlieb says the criticism is unfounded and kratom has no future as a dietary ingredient in the US, the group asks for joint meeting with NIDA to discuss "public health policy that allows for consumers to safely use natural kratom."
Las Vegas Kratom Marketer Rolls Dice On FDA's Mandatory Recall Authority
FDA for the first time exercises its mandatory recall authority over food and supplement products to order Triangle Pharmanaturals, which opened for business in Las Vegas in April 2017, to recall all of the kratom-containing products it has distributed and to cease distributing additional products.The agency also notes in the announcement that it continues to scrutinize kratom's safety unrelated to contamination.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.